Peptide receptor radionuclide therapy with 177Lu-DOTA-TATE as a promising treatment of malignant insulinoma: a series of case reports and literature review

被引：0
|
作者：
D. Magalhães
I. L. Sampaio
G. Ferreira
P. Bogalho
D. Martins-Branco
R. Santos
H. Duarte
机构：
[1] Centro Hospitalar de São João,Endocrinology, Diabetes and Metabolism Department
[2] University of Porto,Faculty of Medicine
[3] University of Porto,Instituto de Investigação e Inovação em Saúde
[4] Instituto Português de Oncologia do Porto,Nuclear Medicine Department
[5] Centro de Investigação do IPO-Porto,Medical Physics, Radiobiology and Radiological Protection Group
[6] Hospital Curry Cabral,Endocrinology Department
[7] Instituto Português de Oncologia de Lisboa,Oncology Department
[8] Instituto Português de Oncologia de Lisboa,Endocrinology Department
来源：
Journal of Endocrinological Investigation | 2019年 / 42卷
关键词：
Insulinoma; Neuroendocrine tumour; Somatostatin receptors; Lutetium; Radiolabeled somatostatin analogues; PRRNT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：249 / 260
页数：11
相关论文
共 50 条
  • [1] Peptide receptor radionuclide therapy with 177Lu-DOTA-TATE as a promising treatment of malignant insulinoma: a series of case reports and literature review
    Magalhaes, D.
    Sampaio, I. L.
    Ferreira, G.
    Bogalho, P.
    Martins-Branco, D.
    Santos, R.
    Duarte, H.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (03) : 249 - 260
  • [2] 177Lu-DOTA-TATE in Peptide Receptor Radionuclide Therapy: first year experience in Turkey
    Kabasakal, L.
    Demirci, E.
    Ocak, M.
    Decristoforo, C.
    Papilla, C.
    Araman, A.
    Uslu, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S428 - S428
  • [3] Peptide receptor radionuclide therapy (PRRT) with [177Lu]Lu-DOTA-TATE in the treatment of malignant insulinoma: a case report of remarkable clinical and imaging response
    Barbosa, D.
    Duarte, H.
    Paula Santos, A.
    Ferro, J.
    Prospero, I.
    Silva, D.
    Gil-Santos, S.
    Calheiros, R.
    Fontao de Castro, S.
    Ferreira, G.
    Teixeira, P.
    Lucena Sampaio, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S219 - S219
  • [4] Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE
    Prado-Wohlwend, S.
    Bernal-Vergara, J. C.
    Utrera-Costero, A.
    Canon-Sanchez, J. R.
    Agudelo-Cifuentes, M.
    Bello-Arques, P.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2022, 41 (01): : 55 - 65
  • [5] Morphologic and metabolic response assessment of 177Lu-DOTA-TATE peptide receptor radionuclide therapy (PRRT) with 68Ga-DOTA-TOC PET/CT
    Gaertner, F. C.
    Hillerer, C.
    Lapa, C.
    Miederer, M.
    D'Alessandria, C.
    Wester, H.
    Schwaiger, M.
    Scheidhauer, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S267 - S267
  • [6] Combined octreotide and peptide receptor radionuclide therapy (90Y-DOTA-TATE) in case of malignant insulinoma
    Fischbach, Jakub
    Gut, Pawel
    Matysiak-Grzes, Magdalena
    Klimowicz, Aleksandra
    Gryczynska, Maria
    Wasko, Ryszard
    Ruchala, Marek
    NEUROENDOCRINOLOGY LETTERS, 2012, 33 (03) : 273 - 278
  • [7] Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours
    Geenen, Lorain
    Nonnekens, Julie
    Konijnenberg, Mark
    Baatout, Sarah
    De Jong, Marion
    Aerts, An
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 102 : 1 - 11
  • [8] Treatment with tandem 90Y-DOTA-TATE and 177Lu-DOTA-TATE of neuroendocrine tumors refractory to conventional therapy
    Seregni, E. C.
    Maccauro, M.
    Mariani, L.
    Coliva, A.
    Chiesa, C.
    Castellani, M.
    Mallia, A.
    Setti, L.
    Padovano, B.
    Pascali, C.
    Buzzoni, R.
    Mazzaferro, V.
    Bombardieri, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S232 - S232
  • [9] Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC
    Wehrmann, Christiane
    Senftleben, Stefan
    Zachert, Carolin
    Mueller, Dirk
    Baum, Richard P.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (03) : 406 - 416
  • [10] Concomitant Dosimetry During Radionuclide Peptide Therapy with 177-Lu-DOTA-tate and 177-Lu-Lanreotide
    Heute, D. R.
    Dobrozemsky, G.
    Traub, T.
    Warwitz, B.
    von Guggenberg, E.
    Gabriel, M.
    Virgolini, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S202 - S202
12345